BMV:XBI Holdings Information

BMV:XBI is an equity ETF with a total of 129 individual holdings. The top holdings are Alnylam Pharmaceuticals stock at 3.35%, Insmed at 3.27%, United Therapeutics at 3.16%, Halozyme Therapeutics at 3.10%, and Incyte at 2.82%.

Total Holdings

129

Top 10 Percentage

27.90%

Asset Class

Equity

ETF Category

Health Care

Assets

98.82B

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ALNY	Alnylam Pharmaceuticals, Inc.	3.35%	403,745
2	INSM	Insmed Incorporated	3.27%	1,230,381
3	UTHR	United Therapeutics Corporation	3.16%	435,981
4	HALO	Halozyme Therapeutics, Inc.	3.10%	2,238,668
5	INCY	Incyte Corporation	2.82%	1,751,032
6	MDGL	Madrigal Pharmaceuticals, Inc.	2.48%	307,768
7	ABBV	AbbVie Inc.	2.47%	629,527
8	NBIX	Neurocrine Biosciences, Inc.	2.45%	970,844
9	REGN	Regeneron Pharmaceuticals, Inc.	2.43%	232,447
10	BIIB	Biogen Inc.	2.38%	905,965
11	BBIO	BridgeBio Pharma, Inc.	2.37%	2,467,844
12	GILD	Gilead Sciences, Inc.	2.31%	1,103,054
13	BMRN	BioMarin Pharmaceutical Inc.	2.30%	2,109,046
14	NTRA	Natera, Inc.	2.24%	722,949
15	AMGN	Amgen Inc.	2.17%	413,056
16	IONS	Ionis Pharmaceuticals, Inc.	2.03%	1,815,793
17	EXEL	Exelixis, Inc.	1.99%	2,909,864
18	EXAS	Exact Sciences Corporation	1.98%	2,166,008
19	CYTK	Cytokinetics, Incorporated	1.97%	2,125,876
20	VRTX	Vertex Pharmaceuticals Incorporated	1.96%	266,517
21	MRNA	Moderna, Inc.	1.93%	4,344,228
22	ROIV	Roivant Sciences Ltd.	1.73%	7,410,782
23	RVMD	Revolution Medicines, Inc.	1.41%	1,918,756
24	CRSP	CRISPR Therapeutics AG	1.41%	1,434,090
25	RNA	Avidity Biosciences, Inc.	1.40%	1,591,610

As of Sep 3, 2025

Showing 25 of 129 holdings

Subscribe to see the full list

Upgrade Now